Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-21 · accession 0001415889-23-016943 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-26 | 2023-12-21 | TBPH | Grant Jeremy T | Dir | A - Grant | $0.00 | +11.8K | 8,826 | New | $0 |
| DM | 2023-12-26 | 2023-12-21 | TBPH | Grant Jeremy T | Dir | A - Grant | $0.00 | +26.3K | 6,578 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-12-21 | A | A | 2,942 | $0.00 | 11,768 | D | — | — | |
| 2 | Common | Ordinary Shares | 2023-12-21 | A | A | 8,826 | $0.00 | 8,826 | D | — | — | |
| 3 | Derivative | Share Option (Right to Buy) | 2023-12-21 | A | A | 19,734 | $0.00 | 19,734 | D | $11.33 · — to 2033-12-21 | 19,734 Ordinary Shares | (F1) The option vests monthly over 24 months of service from the date of grant. |
| 4 | Derivative | Share Option (Right to Buy) | 2023-12-21 | A | A | 6,578 | $0.00 | 6,578 | D | $11.33 · — to 2033-12-21 | 6,578 Ordinary Shares | (F2) This option shall vest monthly over four months of service from the date of grant and will vest in full upon earlier of the four-month anniversary of Jeremy Grant's appointment to the Board or the date of Company's 2024 annual meeting of Shareholders. |